CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...
Phase 3
Atlanta, Georgia, United States and 46 other locations
To evaluate the overall survival of HLA-A\*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investig...
Phase 2
Atlanta, Georgia, United States and 55 other locations
immune related adverse events in participants with stage III-IV melanoma that cannot be removed by surgery who are undergoing nivolumab and ...
Phase 2
Atlanta, Georgia, United States
participants with a type of skin cancer known as melanoma.The objective of this study is to see if the combination of fianlimab and cemipli...
Phase 2, Phase 3
Atlanta, Georgia, United States and 12 other locations
antigen (HLA)-A\*02:01 negative participants with metastatic uveal melanoma (MUM) who will be randomized to receive either IDE196 + crizotin...
Phase 2, Phase 3
Atlanta, Georgia, United States and 65 other locations
to assess nivolumab plus relatlimab fixed-dose combination (FDC) versus nivolumab alone in participants with completely resected stage III-IV melanoma...
Phase 3
Atlanta, Georgia, United States and 171 other locations
The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC...
Phase 2
Atlanta, Georgia, United States and 31 other locations
and/or nivolumab work in treating participants with stage IIIB-D melanoma that can be removed by surgery. Monoclonal antibodies, such as VX1...
Phase 1
Atlanta, Georgia, United States
and pediatric participants after complete resection of Stage IIB/C melanoma with no evidence of disease (NED) who are at high risk for recur...
Phase 3
Atlanta, Georgia, United States and 128 other locations
manner the recurrence-free survival (RFS) of Stage IIIB/C melanoma patients with respect to the standard of care (surgery and adjuvant thera...
Phase 3
Atlanta, Georgia, United States and 33 other locations
Clinical trials
Research sites
Resources
Legal